Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Coiffier

Showing results (1-10 of 249) with videos related to

Pageof 25
Sort By:
Seminars in Oncology|June 1, 2002
Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphomaBertrand Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Increasing chemotherapy intensity in aggressive lymphomas: a renewal?Bertrand Coiffier
Seminars in Oncology|February 1, 2017
Rituximab in the treatment of diffuse large B-cell lymphomasBertrand Coiffier
Current Hematology Reports|December 22, 2004
Treatment of diffuse large B-cell lymphomaBertrand Coiffier
Best Practice & Research. Clinical Haematology|February 8, 2005
Monoclonal antibodies in the treatment of indolent lymphomasBertrand Coiffier
Seminars in Oncology|February 14, 2002
Rituximab in the treatment of diffuse large B-cell lymphomasBertrand Coiffier
Nature Clinical Practice. Oncology|November 3, 2006
Rituximab and CHOP-like chemotherapy in good-prognosis diffuse large-B-cell lymphomaBertrand Coiffier
The Lancet. Oncology|November 22, 2012
Which treatment for high-risk patients with DLBCL?Bertrand Coiffier
Seminars in Hematology|October 10, 2006
Standard treatment of advanced-stage diffuse large B-cell lymphomaBertrand Coiffier
Expert Review of Clinical Pharmacology|August 3, 2017
Pharmacokinetics, efficacy and safety of the rituximab biosimilar CT-P10Bertrand Coiffier
Pageof 25

Showing results (1-10 of 249) with videos related to

Sort By:
Pageof 25
Seminars in Oncology|June 1, 2002
Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphomaBertrand Coiffier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Increasing chemotherapy intensity in aggressive lymphomas: a renewal?Bertrand Coiffier
Seminars in Oncology|February 1, 2017
Rituximab in the treatment of diffuse large B-cell lymphomasBertrand Coiffier
Current Hematology Reports|December 22, 2004
Treatment of diffuse large B-cell lymphomaBertrand Coiffier
Best Practice & Research. Clinical Haematology|February 8, 2005
Monoclonal antibodies in the treatment of indolent lymphomasBertrand Coiffier
Seminars in Oncology|February 14, 2002
Rituximab in the treatment of diffuse large B-cell lymphomasBertrand Coiffier
Nature Clinical Practice. Oncology|November 3, 2006
Rituximab and CHOP-like chemotherapy in good-prognosis diffuse large-B-cell lymphomaBertrand Coiffier
The Lancet. Oncology|November 22, 2012
Which treatment for high-risk patients with DLBCL?Bertrand Coiffier
Seminars in Hematology|October 10, 2006
Standard treatment of advanced-stage diffuse large B-cell lymphomaBertrand Coiffier
Expert Review of Clinical Pharmacology|August 3, 2017
Pharmacokinetics, efficacy and safety of the rituximab biosimilar CT-P10Bertrand Coiffier
Pageof 25